The bradycrotic action of reserpine in atrial fibrillation with rapid ventricular rates: Results in 16 cases with organic heart disease∗
- 31 March 1959
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 3 (3) , 314-324
- https://doi.org/10.1016/0002-9149(59)90216-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- EFFECTS OF RAUWOLFIA SERPENTINA IN PATIENTS WITH HYPERTENSIONThe Lancet Healthy Longevity, 1955
- Further Characterization of Central Effects of Reserpine (Serpasil)American Journal of Physiology-Legacy Content, 1955
- RAUWOLFIA AND PAROXYSMAL TACHYCARDIAJAMA, 1955
- PHARMACOLOGY OF RAUWOLFIA ALKALOIDS, INCLUDING RESERPINEAnnals of the New York Academy of Sciences, 1954
- Zur Pharmakologie des Reserpin, eines neuen Alkaloids ausRauwolfia Serpentina BenthCellular and Molecular Life Sciences, 1953
- Reserpin, der sedative Wirkstoff ausRauwolfia serpentina BenthCellular and Molecular Life Sciences, 1952
- The Relation between Vagal Activity and Auricular Fibrillation in Various Clinical ConditionsNew England Journal of Medicine, 1945
- Studies on the production and maintenance of experimental auricular fibrillationAmerican Heart Journal, 1944
- The mechanism of impaired auriculoventricular conduction in acute rheumatic feverAmerican Heart Journal, 1937
- AURICULAR FIBRILLATION IN HYPERTHYROID PATIENTSJAMA, 1935